KOSPI Racing Toward 2600, Surpasses 2595 as Well

[Asia Economy Reporter Oh Ju-yeon] The KOSPI's upward momentum shows no signs of slowing down. Having risen 13.99% just this month, all eyes are on whether the KOSPI can break through the 2600 mark.

According to the Korea Exchange on the 23rd, as of 10:08 a.m., the KOSPI stood at 2593.81, up 1.58% from the previous trading day, surpassing the 2590 level. During the session, it climbed to 2595.31, setting a new record high.

The KOSPI opened at 2276.61 on the 2nd but surged past 2595.31 during trading on the 23rd, racing toward the 2600 level.

Although the sharp rise throughout November faced concerns of a possible correction due to the recent surge in COVID-19 cases, these forecasts proved unfounded as the KOSPI continuously broke new highs.

In the securities industry, there is analysis suggesting that the KOSPI could surpass its all-time high of 2600 and reach 3000 next year. Fueled by such rosy outlooks, the KOSPI's unstoppable rally continues.

Among the top 15 market capitalization stocks in the KOSPI market, all except Naver (NAVER) rose. Samsung Electronics traded at 66,700 KRW, up 3.09% from the previous day, while SK Hynix and LG Chem each rose about 3%. Celltrion rose 2.02% to break into the 300,000 KRW range, and Samsung SDI also increased 2.91%, trading at 530,000 KRW.

By investor type, foreigners drove the index by purchasing stocks worth 327.4 billion KRW. Individuals and institutions sold stocks worth 226.9 billion KRW and 93 billion KRW, respectively.

The KOSDAQ index also showed an upward trend. On the day, the KOSDAQ index rose 0.53% from the previous day to 874.86. Individuals net bought stocks worth 67.7 billion KRW, while foreigners and institutions sold stocks worth 27 billion KRW and 38.6 billion KRW, respectively.

Among the top market capitalization stocks, all rose, including Celltrion Healthcare (2.23%), Seegene (1.38%), and HL Biopharma (1.56%).

This content was produced with the assistance of AI translation services.